Abstract

BackgroundTriple-negative breast cancer (TNBC) is widely concerning because of high malignancy and poor prognosis. There is increasing evidence that alternative splicing (AS) plays an important role in the development of cancer and the formation of the tumour microenvironment. However, comprehensive analysis of AS signalling in TNBC is still lacking and urgently needed.MethodsTranscriptome and clinical data of 169 TNBC tissues and 15 normal tissues were obtained and integrated from the cancer genome atlas (TCGA), and an overview of AS events was downloaded from the SpliceSeq database. Then, differential comparative analysis was performed to obtain cancer-associated AS events (CAAS). Metascape was used to perform parent gene enrichment analysis based on CAAS. Unsupervised cluster analysis was performed to analyse the characteristics of immune infiltration in the microenvironment. A splicing network was established based on the correlation between CAAS events and splicing factors (SFs). We then constructed prediction models and assessed the accuracy of these models by receiver operating characteristic (ROC) curve and Kaplan–Meier survival analyses. Furthermore, a nomogram was adopted to predict the individualized survival rate of TNBC patients.ResultsWe identified 1194 cancer-associated AS events (CAAS) and evaluated the enrichment of 981 parent genes. The top 20 parent genes with significant differences were mostly related to cell adhesion, cell component connection and other pathways. Furthermore, immune-related pathways were also enriched. Unsupervised clustering analysis revealed the heterogeneity of the immune microenvironment in TNBC. The splicing network also suggested an obvious correlation between SFs expression and CAAS events in TNBC patients. Univariate and multivariate Cox regression analyses showed that the survival-related AS events were detected, including some significant participants in the carcinogenic process. A nomogram incorporating risk, AJCC and radiotherapy showed good calibration and moderate discrimination.ConclusionOur study revealed AS events related to tumorigenesis and the immune microenvironment, elaborated the potential correlation between SFs and CAAS, established a prognostic model based on survival-related AS events, and created a nomogram to better predict the individual survival rate of TNBC patients, which improved our understanding of the relationship between AS events and TNBC.

Highlights

  • Breast cancer is the most common cancer among women in the world, with the highest incidence, and is the second leading cause of cancer-related death, which has strong impacts on national economic and social development [1]

  • Our study revealed alternative splicing (AS) events related to tumorigenesis and the immune microenvironment, elaborated the potential correlation between splicing factors (SFs) and cancer-associated AS events (CAAS), established a prognostic model based on survival-related AS events, and created a nomogram to better predict the individual survival rate of Triple-negative breast cancer (TNBC) patients, which improved our understanding of the relationship between AS events and TNBC

  • The poor prognosis of TNBC is closely related to its early high metastasis rate and recurrence rate [8,9,10], which suggests the urgent need to develop new biomarkers with high accuracy to predict the prognosis of TNBC patients

Read more

Summary

Introduction

Breast cancer is the most common cancer among women in the world, with the highest incidence, and is the second leading cause of cancer-related death, which has strong impacts on national economic and social development [1]. There are many kinds of breast cancers, among which triple negative breast cancer (TNBC) is a wellknown subtype with high invasion, a low survival rate and a lack of effective treatment, accounting for 15–20% of all breast cancers and becoming an intractable problem in the breast cancer field [2]. The anti-programmed cell death (PD)-1 immunotherapy has taken on a favourable effect in TNBC according to the results of recent research, but the efficacy rate of these drugs is still low [5,6,7]. The poor prognosis of TNBC is closely related to its early high metastasis rate and recurrence rate [8,9,10], which suggests the urgent need to develop new biomarkers with high accuracy to predict the prognosis of TNBC patients. Triple-negative breast cancer (TNBC) is widely concerning because of high malignancy and poor prognosis. Comprehensive analysis of AS signalling in TNBC is still lacking and urgently needed

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call